Landry Robert E bought REGN
January 23, 2024 · Form 4 insider transaction
Landry Robert E bought 1,100 shares of Regeneron Pharmaceuticals, Inc. at $378.98 per share, a transaction worth $416.9K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
1,100
Price
$378.98
Total value
$416.9K
InsiderLandry Robert E
RoleDirector
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJanuary 23, 2024
Filing dateJanuary 25, 2024
Shares owned after24,084
OwnershipDirect
10b5-1 planNo
AmendedNo